List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 73 studies with search of: Open Studies | "Warfarin"
Include studies that are not seeking new volunteers.
Hide studies with unknown recruitment status.
  Display Options
Rank Status Study
1 Recruiting Evaluation of Maintenance Dosing vs Loading Dosing Upon Restarting Warfarin Therapy: A Prospective Randomized Trial
Condition: Anticoagulation
Interventions: Drug: warfarin;   Drug: Warfarin
2 Recruiting Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation
Condition: Thromboembolism
Intervention: Drug: Coumadin
3 Recruiting Warfarin Adverse Event Reduction For Adults Receiving Genetic Testing at Therapy INitiation (WARFARIN)
Condition: Warfarin Initiation
Intervention: Device: Warfarin GenoSTAT Test
4 Recruiting Genetics Informatics Trial (GIFT) of Warfarin to Prevent DVT
Condition: Thromboembolism
Interventions: Other: Pharmacogenetic Warfarin Initiation;   Other: Clinical Warfarin Initiation (non-pharmacogenetic)
5 Recruiting Evaluation of the WATCHMAN LAA Closure Device in Patients With Atrial Fibrillation Versus Long Term Warfarin Therapy
Conditions: Atrial Fibrillation;   Stroke
Interventions: Device: WATCHMAN Device;   Drug: Warfarin
6 Recruiting Assessing the Clinical Benefits of a Pharmacogenetics-Guided Dosing Regiment for Calculating Warfarin Maintenance Dose
Condition: Indications for Warfarin Therapy
Intervention: Drug: Warfarin Sodium
7 Recruiting Genotype-Guided Warfarin Therapy Trial
Conditions: Atrial Fibrillation;   Deep Vein Thrombosis;   Pulmonary Embolism;   Artificial Heart Valve
Interventions: Other: Genotype-guided dose determination;   Other: Non-genotype guided warfarin dosing
8 Recruiting Clinical and Economic Implications of Genetic Testing for Warfarin Management
Condition: Blood Coagulation Disorders
Intervention: Drug: Warfarin
9 Recruiting Dabigatran Etexilate in Patients With Mechanical Heart Valves
Condition: Heart Valve Diseases
Interventions: Drug: dabigatran etexilate low dose;   Drug: dabigatran etexilate intermediate dose;   Drug: dabigatran etexilate high dose;   Drug: warfarin 1mg;   Drug: warfarin 3mg;   Drug: warfarin 5mg
10 Recruiting Follow on Study From RE-ALIGN
Conditions: Thromboembolism;   Heart Valve Prosthesis
Interventions: Drug: dabigatran etexilate low dose;   Drug: dabigatran etexilate intermediate dose;   Drug: dabigatran etexilate high dose;   Drug: warfarin 1mg;   Drug: warfarin 3mg;   Drug: warfarin 5mg
11 Recruiting Early Identification of Warfarin Maintenance Dosage
Condition: Atrial Fibrillation
Intervention: Genetic: Calculate warfarin dose using demographic/genetic algorithm
12 Recruiting Bridge or Continue Coumadin for Device Surgery Randomized Controlled Trial
Condition: Hematoma
Interventions: Drug: low molecular weight heparin or unfractionated heparin;   Drug: Warfarin or coumadin
13 Recruiting Clarification of Optimal Anticoagulation Through Genetics
Conditions: Stroke;   Venous Thrombosis;   Atrial Fibrillation;   Atrial Flutter
Interventions: Behavioral: Genotype-guided dosing algorithm for warfarin;   Behavioral: Clinical-guided dosing algorithm for warfarin
14 Recruiting Extended Duration of Oral Anticoagulant Therapy After a First Episode of Idiopathic Pulmonary Embolism: a Randomized Controlled Trial. "PADIS-PE" Study.
Condition: Pulmonary Embolism
Interventions: Drug: warfarin;   Drug: placebo of warfarin
15 Recruiting A Pharmacokinetics Study of the Effects of GSK2118436 on Warfarin, the Effects of Ketoconazole and Gemfibrozil on GSK2118436, and the Effects of Repeat Doses of GSK2118436 in Subjects With BRAF Mutant Solid Tumors
Conditions: Drug Interactions;   BRAF;   Cancer
Interventions: Drug: Warfarin;   Drug: Ketoconazole;   Drug: Gemfibrozil;   Drug: GSK2118436 150mg;   Drug: GSK2118436 75mg
16 Recruiting Aortic Arch Related Cerebral Hazard Trial (ARCH)
Conditions: Brain Infarction;   Transient Ischemic Attack;   Embolism
Interventions: Drug: Warfarin;   Drug: Clopidogrel-aspirin
17 Recruiting A Drug Interaction Study to Assess the Effect of LY317615 on the Metabolic Pathway of Warfarin
Conditions: Solid Tumor;   Lymphoma, Malignant
Interventions: Drug: warfarin;   Drug: enzastaurin
18 Recruiting Use of Phytonadione to Reduce International Normalized Ratio (INR) Variability in Patients on Long-term Warfarin Therapy
Condition: Coagulation Delay
Interventions: Dietary Supplement: phytonadione;   Drug: none-control group
19 Not yet recruiting Dexpramipexole and Warfarin Drug Drug Interaction (DDI) Study
Condition: Healthy Volunteers
Interventions: Drug: Warfarin;   Drug: Dexpramipexole
20 Recruiting Long-Term Innohep® Treatment Versus a Vitamin K Antagonist (Warfarin) for the Treatment of Venous Thromboembolism (VTE) in Cancer
Condition: Venous Thromboembolism
Interventions: Drug: Warfarin;   Drug: Innohep®

Previous Page Studies Shown (1-20) Next Page (21-40)
† Indicates status has not been verified in more than two years
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services